Results 211 to 220 of about 755,200 (268)

An anti-CEA affibody showing high-definition staining in human pancreatic cancer tissue sections and selective tumor targeting in vivo. [PDF]

Transl Oncol
Nilvebrant J, Moro CF, Papalanis E, Novin MO, Ding H, Li R, Oroujeni M, Selvam A, Bozóky B, Gräslund T, Szekerczes T, Sandalova T, Salter H, Achour A, Tolmachev V, Björnstedt M, Nygren PÅ.   +16 more
europepmc   +1 more source

Prognostic Impact of European LeukemiaNet Genetic Risk Stratification System in Adult Patients With Acute Myeloid Leukemia

Aging and Cancer, EarlyView.
This study aimed to evaluate the prognostic value of ELN2017 in predicting survival outcomes and to assess the impact of clinical and molecular factors such as age, FLT3 and NPM1 mutations, and allogeneic hematopoietic stem cell transplantation (allo‐HSCT).
Mobina Shrestha, Bishwas Mandal, Vishal Mandal, Asis Shrestha, Amir Babu Shrestha   +4 more
wiley   +1 more source

Comparative Preclinical Evaluation of the Tumor-Targeting Properties of Radioiodine and Technetium-Labeled Designed Ankyrin Repeat Proteins for Imaging of Epidermal Growth Factor Receptor Expression in Malignant Tumors. [PDF]

Int J Mol Sci
Larkina M, Yanovich G, Hasnowo LA, Varvashenya R, Yuldasheva F, Tretyakova M, Plotnikov E, Zelchan R, Schulga A, Konovalova E, Ziganshin R, Belousov MV, Tolmachev V, Deyev SM.   +13 more
europepmc   +1 more source

Stroma content in triple-negative breast cancer spheroid models regulates penetration and efficacy of tumor-targeting Salmonella typhimurium. [PDF]

NPJ Breast Cancer
Zhan Y, Saha B, Burkel B, Leaman EJ, Ponik SM, Behkam B.   +5 more
europepmc   +1 more source

A tumor-targeting black phosphorus-based nanoplatform for controlled chemo-photothermal therapy of breast cancer. [PDF]

Mater Today Bio
Yang L, Zhang Y, Liu J, Wang X, Zhang L, Wan H.   +5 more
europepmc   +1 more source

The Protein Corona on Nanoparticles for Tumor Targeting in Prostate Cancer-A Review of the Literature and Experimental Trial Protocol. [PDF]

Biology (Basel)
Bevilacqua G, Corvino R, Capriotti AL, Montone CM, Moriconi M, Salciccia S, Brunelli V, Santarelli V, Sciarra B, Laganà A, Santini D, Sciarra A, Gentilucci A.   +12 more
europepmc   +1 more source

Next-Generation Tumor Targeting with Genetically Engineered Cell Membrane-Coated Nanoparticles. [PDF]

Biodes Res
Shubhra QTH, Cai X, Cai Q.
europepmc   +1 more source

Next-generation cell-penetrating antibodies for tumor targeting and RAD51 inhibition. [PDF]

Oncotarget
Rackear M, Quijano E, Ianniello Z, Colón-Ríos DA, Krysztofiak A, Abdullah R, Liu Y, Rogers FA, Ludwig DL, Dwivedi R, Bleichert F, Glazer PM.   +11 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Targeting the Tumor-Tumor Microenvironment Crosstalk

Expert Opinion on Therapeutic Targets, 2023
Cancer development and progression is a complex process influenced by co-evolution of the cancer cells and their microenvironment. However, traditional anti-cancer therapy is mostly targeted toward cancer cells. To improve the efficacy of cancer drugs, the complex interactions between the tumor (T) and the tumor microenvironment (TME) should be ...
Sunil S. Badve, Yesim Gökmen-Polar
openaire   +2 more sources